Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures

Documenti analoghi

• Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis
  di: Jing Ling, et al.
  Pubblicazione: (2025)
• Exploring population and sex‐specific disease trajectories for multimorbidities among individuals with overweight or obesity: A retrospective cohort study in UK biobank
  di: Qianhui Lu, et al.
  Pubblicazione: (2025)
• Real‐life use of liraglutide 3 mg in obesity management: The SAX‐RL study
  di: Marc Goëau‐Brissonnière, et al.
  Pubblicazione: (2024)
• A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
  di: Nadine Beetz, et al.
  Pubblicazione: (2024)
• Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
  di: Ali Kapan, et al.
  Pubblicazione: (2025)